Klinische Studie
Neoadjuvant Radiochemotherapy versus Chemotherapy for Patients with Locally Advanced, Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ)(RACE)Neoadjuvant Radiochemotherapy versus Chemotherapy for Patients with Locally Advanced, Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction
Krankheitsentität(en)
Speiseröhre
StudientypInterventionsstudiePhase III
StudientypInterventionsstudiePhase III
Wesentliche EinschlusskriterienHistologically proven, locally advaced and potentially resectable adenoCA of the gastroesophageal junction
Patients must be candidates for potential curative resection as determined by the treating surgeon
ECOG 0-1
Wesentliche AusschlusskriterienEvidence of metastatic disease
Past or current history of other malignancies
Statusrekrutierend
Ansprechpartner & KontaktUniversitätsklinikum RegensburgInnere Medizin IStudienzentrale0941 9447063studienzentrum.innere1(at)ukr.de